Bone density in women with endometriosis

Panminerva Medica

Volumn 40, Issue 2, 1998, Pages 126-127

  Colacurci, N ^a   De Seta, L ^a   Passaro, M ^a   Scala, P ^a   De Franciscis, P ^a   Zarcone, R ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NONE   (Italy)

Author keywords

Bone density; Endometriosis; Osteoporosis

Indexed keywords

ADULT; ARTICLE; BONE DENSITY; CASE CONTROL STUDY; ENDOMETRIOSIS; FEMALE; HUMAN; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTMENOPAUSE OSTEOPOROSIS; RISK FACTOR;

ADULT; BONE DENSITY; CASE-CONTROL STUDIES; ENDOMETRIOSIS; FEMALE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; RISK FACTORS;

EID: 0032087006     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Comite F, Delman M, Hutchinson-William K, De Cherney AH, Jensen P. Reduced bone mass in reproductive-aged women with endometriosis. J Clin Endocrinol Metab 1989;69:837-42.
2. Lane N, Baptista J, Snow-Harter C. Bone mineral density of the lumbar spine in endometriosis subjects compared to an age-similar control population. J Clin Endocrinol Metab 1991;72:510-4.
3. Dochi T, Lees B, Sidhu M, Stevenson JC. Bone density and endometriosis. Fertil Steril 1994,61:175-7.
4. Stevenson JC, Lees B, Gardner R, Shaw RW. A companson of the skeletal effects of goserelin and danazol in premenopausal womne with endometriosis. Horm Res 1989;32 (suppl 1):161.
5. Matta WH, Shaw RW, Hesp R, Evans R. Reversible trabecular bone density loss following induced hypoestrogenism with the GnRH analogue buserilin in premenopausal women Clin Endocrinol 1988;29:45